Immune-mediated adverse events were reported to be the primary reason for discontinuation in the vibostolimab/pembrolizumab coformulation arm. Merck has made the ...
An analysis of weight-related measures showed weight loss with semaglutide continued through week 65 and was sustained through the rest of the 4-year trial. Treatment with semaglutide 2.4mg once ...
Access to abortion has gotten tougher for American women, with 14 states now prohibiting nearly all such procedures, and 3 more banning after just 6 weeks of pregnancy. HealthDay News — While some ...
Even with health care insurance, users report difficulty paying for the medication. HealthDay News — One in 8 adults (12%) say they have ever taken a glucagon-like peptide-1 receptor agonist (GLP-1 RA ...
The information provided in response to the FDA’s Complete Response Letter "constituted a major amendment to the NDA" requiring more time for review. The Food and Drug Administration (FDA) has ...
Odds of primary vaccine failure were increased in association with cesarean birth. HealthDay News — At the individual level, there is high predictability for measles antibody dynamics from birth, ...
No clinically significant cases of essential fatty acid deficiency were observed in short term pediatric clinical studies. The Food and Drug Administration (FDA) has expanded the approval of ...
Increases of 333% in teens aged 15 to 19 years, 185% in those aged 20 to 24 years, 45% in those aged 40 to 44 years. HealthDay News — For individuals aged younger than 45 years, the incidence of ...
A regulatory decision is expected in the third quarter of 2024. The Food and Drug Administration (FDA) has accepted the supplemental New Drug Application (sNDA) for vibegron for the treatment of men ...
A regulatory decision for expansion of the CRSwNP indication to adolescents is expected on September 15, 2024. The Food and Drug Administration (FDA) has accepted for Priority Review the supplemental ...
Findings seen for Black and Hispanic patients with atrial fibrillation versus White patients. HealthDay News — Historical disparities in initiation of direct oral anticoagulants (DOACs) for atrial ...
Recommendations include ID of sociodemographic factors, patient preferences that influence access to and use of hearing health care. HealthDay News — In a clinical practice guideline issued by the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results